deltatrials
Completed NCT00750672

Follow-up Care After Treatment for Endometrial Cancer

Follow-up After Primary Therapy for Endometrial Cancer; Implementation of a Cancer Care Ontario Guideline: A Pilot Evaluation Study.

Sponsor: Ottawa Hospital Research Institute

Conditions Endometrial Neoplasm
Updated 6 times since 2017 Last updated: Jul 11, 2012 Started: Aug 31, 2008 Primary completion: Sep 30, 2009 Completion: Feb 28, 2010

This observational or N/A phase trial investigates Endometrial Neoplasm and is currently completed. Ottawa Hospital Research Institute leads this study, which shows 6 recorded versions since 2008 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Change History

6 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Jun 2018 — Jan 2021 [monthly]

    Completed

  5. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NA → None

▶ Show 1 earlier version

  1. Jan 2017 — Apr 2018 [monthly]

    Completed NA

    First recorded

Aug 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Ottawa Hospital Research Institute
  • Ottawa Regional Cancer Centre
Data source: Ottawa Hospital Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • Ottawa, Canada